Meet Our Advisory Board

Andy Richardson, a pharmacologist by original training, has over 35 years of senior leadership experience in the pharmaceutical and CRO sectors principally in clinical data management, and study operational logistics and delivery. He has a long-running interest in optimizing and improving operational efficiency and has published extensively and regularly on these topics. Recent work has focused on the use of the HL7 FHIR standards to improve and enhance the accuracy and timeliness of specifying, collecting and confirming clinical research data directly from study sites.

Baljit (Boo) Samra is currently an Executive Vice President at Parexel, where he oversees clinical operations for the Asia-Pacific region and central monitoring globally. Prior to this position, he was Chief Operating Officer (COO) at Duke Clinical Research Institute (DCRI).

Boo has over 30 years of experience in clinical trials, primarily with global CROs and academic medical centers, and is a seasoned leader with global expertise in operations, digital health and technologies, sales and account leadership, quality management, and general management. His global experience extends beyond the Asia-Pacific region to include India, Europe, and the United States. He also serves on advisory boards.

With over 35+ years of experience in clinical data science, David is a seasoned executive who leads global teams to deliver strategic, scalable, and regulatory-compliant data solutions across the pharmaceutical and CRO sectors. He was formerly the Global Head of Data Strategy at Fortrea (formerly Labcorp), he had oversight of a team of 350+ professionals across Asia, Europe, and the Americas, transforming data management, biometrics, and clinical systems to accelerate drug development.

David has held senior leadership roles at GSK, Covance, ICON, and Quintiles, where he directed global programming operations, implemented CDISC standards, optimized clinical data pipelines, and supported major regulatory submissions. Known for building future-ready data organizations and mentoring global talent, David is committed to shaping the next generation of clinical data strategy.

Sam is a leading subject matter expert in all aspects of Real World Evidence (RWE), with 35+ years’ research experience in the Pharmaceutical and CRO industries. She is an outstanding drug development leader who has maintained an extensive knowledge of drug development processes in clinical research and project management, encompassing all development phases from pre-clinical through to post-marketing research and across a wide therapeutic range, including oncology (immuno-oncology), immunology, rare diseases, medical devices, neurology and psychiatry.

Alongside her wide therapeutic experience is a truly global expertise in operational delivery, having worked in over 50 countries worldwide, including the Americas (North and South), Europe, Asia-Pacific, the Middle East and North Africa and Sub-Saharan Africa.

Sam’s appetite, attitude, and focus allow her to execute projects in a way that makes others want to do more. Her passion for people and love for technology and process make her excellent at leading teams and bringing excitement, vision and creative solutions to the complex world of RWE, medical devices and clinical trials.

Patrick Genyn is a creative and strategic leader with over 35 years of experience in the pharmaceutical industry, specializing in clinical data management, interoperability standards, and the modernization of clinical trial operations. A long-time advocate for CDISC and HL7 FHIR, he has led numerous initiatives to streamline clinical research through structured, standards-based data exchange. Patrick is currently focused on applying HL7 FHIR to bridge the gap between clinical care and clinical research—aligning real-world clinical data with protocol-driven requirements to enable more efficient, scalable, and semantically interoperable trials.

With over 30 years in clinical research, Paul specialises in decentralised clinical trials, with a particular focus on community-based models including home nursing. A co-founder of the Medical Research Network (MRN) in 2006, Paul was responsible for creating a global HCP network and designing solutions for regulatory compliant in-home clinical trial delivery, in addition to overseeing the contracts & proposals teams.

Prior to this, Paul served as Director of Data Management at PAREXEL International, where he led a team of over 100 professionals and oversaw all aspects of clinical data operations within the UK.

Paul now advises and supports on DCT strategy, design & implementation and is also representing MRN on the IMI funded Trials@Home project, where he is part of the Quality Working Group and oversees MRN's involvement in the RADIAL study. Paul is a frequent industry speaker and trainer, and in his spare time he is also a volunteer Director of WSML (community-based sporting venue) and a part-time professional soccer referee.

Shafi is a seasoned expert in Biometrics with over 30 years of experience in the pharmaceutical industry. He has supported a wide range of organizations, from global pharmaceutical companies to niche CROs across Europe, the United States, and Japan. Throughout his career, Shafi has consistently delivered high-quality results with speed and precision.

His deep understanding of diverse working strategies, computing environments, and operational frameworks has given him unique insight into what drives success in complex clinical and regulatory settings. With hands-on experience across the full spectrum of biometrics operations, Shafi’s approach is rooted in pragmatism and efficiency.

Whether it's CDISC dataset generation, clinical trial reporting, pharmacometrics support, or implementing risk-based monitoring, his priority is always to apply the most effective and streamlined solution, tailored to the challenge, saving clients valuable time and resources while maintaining the highest standards of quality.

With over 35 years at the forefront of the Pharmaceutical and Contract Research Organisation (CRO) and Technology industries, Subash is a transformative executive leader known for driving global growth, innovation, and clinical excellence. He has built and led high-performing technical and clinical teams across the globe, delivering end-to-end clinical research, data management, and regulatory compliant solutions to some of the world’s prominent pharmaceutical, CRO and Technology companies.

Subash has successfully launched and implemented leading-edge clinical technologies—modernising operations and aligning businesses with evolving industry and technology standards. A trusted strategic partner, he has played a pivotal role in designing and deploying enterprise-level clinical trial systems that enhance efficiency, data integrity, and regulatory compliance on a global scale.

Qualified in Biochemistry, Information Systems Management and Business Administration he is an executive with extensive experience at Board level. Subash brings a rare blend of visionary leadership, operational acumen and humour. He thrives on building scalable organisations, mentoring future leaders, and enabling innovation that delivers lasting impact across the life sciences sector.